Derm-Biome Pharmaceuticals, Inc. reports Positive Results from a Preclinical Study in Atopic Dermatitis: its new generation of compounds are significantly more effective than FDA-approved topical AD drug crisaborole
…
Menu
In the News
Timeline
Who we’re working with
Acne / Rosacea
Atopic Dermatitis
Pre-Cancer / Skin Cancer
Anti-Aging / Skin Aging
About Us
Our Purpose
Our Team
Investor Inquiries:
Gordon Eberwein
geberwein@derm-biome.com
derm-biomepharmaceuticals.com